Entry inhibitors as topical microbicides to prevent HIV-1 sexual transmission

by Moore, John P
Published 2006

HIV-1 Membrane Fusion: Targets of Opportunity

by Doms, Robert W., Moore, John P.
Published 2000

Good CoP, bad CoP? Interrogating the immune responses to primate lentiviral vaccines

by Klasse, Per Johan, Moore, John P
Published 2012

Editorial: Current advances and challenges in understanding plant desiccation tolerance

by Moore, John P., Farrant, Jill M.
Published 2015

Which Topical Microbicides for Blocking HIV-1 Transmission Will Work in the Real World?

by Klasse, Per Johan, Shattock, Robin J, Moore, John P
Published 2006

Evolution of the HIV-1 envelope glycoproteins with a disulfide bond between gp120 and gp41

by Sanders, Rogier W, Dankers, Martijn M, Busser, Els, Caffrey, Michael, Moore, John P, Berkhout, Ben
Published 2004

Escape of HIV-1 from a Small Molecule CCR5 Inhibitor Is Not Associated with a Fitness Loss

by Anastassopoulou, Cleo G, Marozsan, Andre J, Matet, Alexandre, Snyder, Amy D, Arts, Eric J, Kuhmann, Shawn E, Moore, John P
Published 2007

Overexpression of the grapevine PGIP1 in tobacco results in compositional changes in the leaf arabinoxyloglucan network in the absence of fungal infection

by Nguema-Ona, Eric, Moore, John P, Fagerström, Alexandra D, Fangel, Jonatan U, Willats, William GT, Hugo, Annatjie, Vivier, Melané A
Published 2013

Antibody potency relates to the ability to recognize the closed, pre-fusion form of HIV Env

by Guttman, Miklos, Cupo, Albert, Julien, Jean-Philippe, Sanders, Rogier W., Wilson, Ian A., Moore, John P., Lee, Kelly K.
Published 2015

Interaction of Chemokine Receptor CCR5 with its Ligands: Multiple Domains for HIV-1 gp120 Binding and a Single Domain for Chemokine Binding

by Wu, Lijun, LaRosa, Greg, Kassam, Nasim, Gordon, Cynthia J., Heath, Heidi, Ruffing, Nancy, Chen, Howard, Humblias, Jason, Samson, Michel, Parmentier, Marc, Moore, John P., Mackay, Charles R.
Published 1997

HIV-1 Antigen–specific and –nonspecific B Cell Responses Are Sensitive to Combination Antiretroviral Therapy

by Morris, Lynn, Binley, James M., Clas, Brian A., Bonhoeffer, Sebastian, Astill, Thomas P., Kost, Rhonda, Hurley, Arlene, Cao, Yunzhen, Markowitz, Martin, Ho, David D., Moore, John P.
Published 1998

Blockade of Attachment and Fusion Receptors Inhibits HIV-1 Infection of Human Cervical Tissue

by Hu, Qinxue, Frank, Ines, Williams, Vennansha, Santos, John J., Watts, Patricia, Griffin, George E., Moore, John P., Pope, Melissa, Shattock, Robin J.
Published 2004

Clinical Adjuvant Combinations Stimulate Potent B-Cell Responses In Vitro by Activating Dermal Dendritic Cells

by Matthews, Katie, Chung, Nancy P. Y., Klasse, Per Johan, Moutaftsi, Magda, Carter, Darrick, Salazar, André M., Reed, Steven G., Sanders, Rogier W., Moore, John P.
Published 2013

An HIV-1 Envelope Glycoprotein Trimer with an Embedded IL-21 Domain Activates Human B Cells

by Isik, Gözde, Chung, Nancy P. Y., van Montfort, Thijs, Menis, Sergey, Matthews, Katie, Schief, William R., Moore, John P., Sanders, Rogier W.
Published 2013

Comparative Immunogenicity of Evolved V1V2-Deleted HIV-1 Envelope Glycoprotein Trimers

by Bontjer, Ilja, Melchers, Mark, Tong, Tommy, van Montfort, Thijs, Eggink, Dirk, Montefiori, David, Olson, William C., Moore, John P., Binley, James M., Berkhout, Ben, Sanders, Rogier W.
Published 2013

Presenting native-like HIV-1 envelope trimers on ferritin nanoparticles improves their immunogenicity

by Sliepen, Kwinten, Ozorowski, Gabriel, Burger, Judith A., van Montfort, Thijs, Stunnenberg, Melissa, LaBranche, Celia, Montefiori, David C., Moore, John P., Ward, Andrew B., Sanders, Rogier W.
Published 2015

SHIV-162P3 Infection of Rhesus Macaques Given Maraviroc Gel Vaginally Does Not Involve Resistant Viruses

by Tsibris, Athe M. N., Pal, Urboshi, Schure, Allison L., Veazey, Ronald S., Kunstman, Kevin J., Henrich, Timothy J., Klasse, P. J., Wolinsky, Steven M., Kuritzkes, Daniel R., Moore, John P.
Published 2011

A stabilized HIV-1 envelope glycoprotein trimer fused to CD40 ligand targets and activates dendritic cells

by Melchers, Mark, Matthews, Katie, de Vries, Robert P, Eggink, Dirk, van Montfort, Thijs, Bontjer, Ilja, van de Sandt, Carolien, David, Kathryn, Berkhout, Ben, Moore, John P, Sanders, Rogier W
Published 2011

HIV-1 gp120 Mannoses Induce Immunosuppressive Responses from Dendritic Cells

by Shan, Meimei, Klasse, Per Johan, Banerjee, Kaustuv, Dey, Antu K, Iyer, Sai Prasad N, Dionisio, Robert, Charles, Dustin, Campbell-Gardener, Lila, Olson, William C, Sanders, Rogier W, Moore, John P
Published 2007

Differential binding of neutralizing and non-neutralizing antibodies to native-like soluble HIV-1 Env trimers, uncleaved Env proteins, and monomeric subunits

by Yasmeen, Anila, Ringe, Rajesh, Derking, Ronald, Cupo, Albert, Julien, Jean-Philippe, Burton, Dennis R, Ward, Andrew B, Wilson, Ian A, Sanders, Rogier W, Moore, John P, Klasse, Per Johan
Published 2014